LH
Labcorp Holdings Inc.
NYSE · USHealthcareMedical - Equipment & Services
$281.48-0.66%
Price as of Jul 20, 2026
LH financials
Labcorp Holdings Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $14.0B | $13.0B | $12.2B | $11.9B |
| Cost of revenue | $10.2B | $9.4B | $8.8B | $8.2B |
| Gross profit | $3.7B | $3.6B | $3.4B | $3.7B |
| Operating expenses | $2.2B | $2.5B | $2.6B | $2.3B |
| Operating income | $1.5B | $1.1B | $725.6M | $1.4B |
| Net income | $876.5M | $746.0M | $418.0M | $1.3B |
| EBITDA | $2.0B | $1.8B | $1.3B | $2.0B |
| Basic EPS | $10.54 | $8.89 | $4.80 | $14.04 |
| Diluted EPS | $10.46 | $8.84 | $4.77 | $13.96 |
| Balance sheet | ||||
| Cash & equivalents | $532.3M | $1.5B | $536.8M | $320.6M |
| Total assets | $18.4B | $18.4B | $16.7B | $20.2B |
| Total liabilities | $9.8B | $10.3B | $8.8B | $10.0B |
| Stockholders’ equity | $8.6B | $8.1B | $7.9B | $10.1B |
| Total debt | $7.2B | $7.3B | $6.0B | $6.2B |
| Net debt | $6.7B | $5.8B | $5.4B | $5.9B |
| Cash flow | ||||
| Operating cash flow | $1.6B | $1.6B | $1.3B | $2.0B |
| Capital expenditure | -$434.5M | -$489.9M | -$453.6M | -$481.9M |
| Free cash flow | $1.2B | $1.1B | $874.1M | $1.5B |
| Dividends paid | -$240.7M | -$243.1M | -$254.0M | -$195.2M |
| Share repurchases | -$450.0M | -$250.1M | -$1.0B | -$1.2B |